
Loading, please wait...

Loading, please wait...

Researchers examined 44 prediabetic/T2D patients and found that empagliflozin reduced fasting plasma glucose, HbA1c, ferritin, CRP, interleukin-6 (IL-6), and uric acid levels. Total iron-binding capacity increased. A positive correlation existed between ferritin and IL-6, and ferritin and uric acid. Empagliflozin impacts inflammation and iron metabolism, with reduced ferritin potentially resulting from decreased inflammation.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers examined 44 prediabetic/T2D patients and found that empagliflozin reduced fasting plasma glucose, HbA1c, ferritin, CRP, interleukin-6 (IL-6), and uric acid levels. Total iron-binding capacity increased. A positive correlation existed between ferritin and IL-6, and ferritin and uric acid. Empagliflozin impacts inflammation and iron metabolism, with reduced ferritin potentially resulting from decreased inflammation.
2 months ago

Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today